Patents by Inventor Stephanie Yaung

Stephanie Yaung has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • NON-INVASIVE TEST TO PREDICT RESPONSE TO THERAPY IN COLORECTAL CANCER PATIENTS
    Publication number: 20230083203
    Abstract: The invention is a method of predicting response to therapy in a colorectal cancer patient, the method comprising analysis of circulating tumor DNA from a patient's sample.
    Type: Application
    Filed: October 14, 2022
    Publication date: March 16, 2023
    Inventors: John Lee, Alexander Lovejoy, John Palma, Ulrich-Peter Rohr, Lijing Yao, Stephanie Yaung
  • Non-invasive test to predict response to therapy in colorectal cancer patients
    Patent number: 11519037
    Abstract: The invention is a method of predicting response to therapy in a colorectal cancer patient, the method comprising analysis of circulating tumor DNA from a patient's sample.
    Type: Grant
    Filed: August 7, 2019
    Date of Patent: December 6, 2022
    Assignee: ROCHE SEQUENCING SOLUTIONS, INC.
    Inventors: John Lee, Alexander Lovejoy, John Palma, Ulrich-Peter Rohr, Lijing Yao, Stephanie Yaung
  • METHOD OF MONITORING EFFECTIVENESS OF IMMUNOTHERAPY OF CANCER PATIENTS
    Publication number: 20210292851
    Abstract: The invention is a method of determining a likelihood that a cancer patient will respond to immunotherapy based on a mutation metric obtained by sequencing a small panel of nucleic acid targets in patient's cell-free DNA.
    Type: Application
    Filed: July 29, 2019
    Publication date: September 23, 2021
    Inventors: Aarthi Balasubramanyam, Yuqiu Jiang, John Palma, Namrata Patil, Johnny Wu, Stephanie Yaung, Wei Zou
  • Precise microbiota engineering at the cellular level
    Patent number: 10752906
    Abstract: Stably immunized cells and methods of making stably immunized cells are provided. Methods of altering the microbiota of an ecological environment are provided. Methods of modifying target chromosomes are provided. Methods of delivering genetic material to target cells are provided.
    Type: Grant
    Filed: November 5, 2014
    Date of Patent: August 25, 2020
    Assignee: President and Fellows of Harvard College
    Inventors: Kevin M. Esvelt, Stephanie Yaung
  • NON-INVASIVE TEST TO PREDICT RESPONSE TO THERAPY IN COLORECTAL CANCER PATIENTS
    Publication number: 20190360060
    Abstract: The invention is a method of predicting response to therapy in a colorectal cancer patient, the method comprising analysis of circulating tumor DNA from a patient's sample.
    Type: Application
    Filed: August 7, 2019
    Publication date: November 28, 2019
    Inventors: John Lee, John Palma, Ulrich-Peter Rohr, Lijing Yao, Stephanie Yaung
  • NOVEL MUTATIONS IN ANAPLASTIC LYMPHOMA KINASE PREDICTING RESPONSE TO ALK INHIBITOR THERAPY IN LUNG CANCER PATIENTS
    Publication number: 20170349953
    Abstract: The invention comprises novel methods and compositions for detecting whether a patient will be responsive to ALK inhibitors and methods of treating the patient.
    Type: Application
    Filed: June 1, 2017
    Publication date: December 7, 2017
    Inventors: Alexander Lovejoy, Stephanie Yaung, Aarthi Balasubramanyam, John Palma
  • Precise Microbiota Engineering at the Cellular Level
    Publication number: 20160348120
    Abstract: Stably immunized cells and methods of making stably immunized cells are provided. Methods of altering the microbiota of an ecological environment are provided. Methods of modifying target chromosomes are provided. Methods of delivering genetic material to target cells are provided.
    Type: Application
    Filed: November 5, 2014
    Publication date: December 1, 2016
    Applicants: President and Fellows of Harvard College, President and Fellows of Harvard College
    Inventors: Kevin M. Esvelt, Stephanie Yaung